Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The MDUK Oxford Neuromuscular Centre (directed by Professor Matthew Wood) was founded in 2019 by the Muscular Dystrophy UK and the University of Oxford  to focus on the urgent mission of accelerating the discovery, development and deployment of new medicines to combat devastating neuromuscular diseases. The Centre builds on the already excellent research, training and patient care in Oxford to drive the development of novel experimental therapies more rapidly and increase national clinical trial capacity in neuromuscular diseases.

Please see for more information